Author: CATIE | Page 13

Gendering the Scene: We need to listen to women and gender-diverse people who use drugs

June 22, 2020 • By Sandra Ka Hon Chu and Cécile Kazatchkine

Over the past several years, Canada has been in the grip of an overdose crisis. We have seen the devastating effects both of a contaminated drug supply and of punitive laws that restrict access of people who use drugs to effective treatment and support. Now we are facing the twin crisis of the novel coronavirus disease (COVID-19) pandemic, which has radically altered the way we interact with one another and affected the drug supply chain.

Talking about HIV during COVID-19: How the Strong Medicine Guide can help you structure your conversations

June 19, 2020 • By Jessica Chenery, Harlan Pruden, Felicia Tebb and Amanda Porter

Are you interested in hosting a conversation in your community or organization about HIV? Looking for some tips on how to do this? Look no further than the just launched Strong Medicine Guide, an accompanying resource for the Strong Medicine film that came out in 2018.

Beyond prescriptions: Equitable hepatitis C care for people who inject drugs

June 10, 2020 • By Trevor Goodyear

In Canada, people who inject drugs have led long, hard-fought, and ongoing campaigns for human rights-based drug policies and health services. Unfortunately, this community activism has often been met with varying degrees of government and healthcare system inaction.

Redeployed: A hepatology nurse on the COVID-19 front lines

May 19, 2020 • By Lesley Gallagher

I have worked as a nurse in the Downtown Eastside of Vancouver, or what we call DTES, for almost 20 years, first for the University of British Columbia and now for the Vancouver Coastal Health Authority, based at Pender Community Health Centre.

Access to treatments for COVID-19: Lessons learned from early HIV activism

May 15, 2020 • By Louise Binder and Ron Rosenes

Much of what Dr. Anthony Fauci, the esteemed head of the U.S. National Institute of Allergy and Infectious Diseases (NIAID), learned about clinical trials for the novel coronavirus disease (COVID-19), he learned from sparring with HIV community activists.

Harm reduction during a pandemic

April 28, 2020 • By Brandon Hinton

The novel coronavirus disease (COVID-19) has proven to be a struggle for everyone, regardless of their lifestyle, but people who use drugs are finding it especially difficult to navigate these unprecedented waters. Whether they’re currently using, en route to recovery, or in active recovery, this virus has and will continue to challenge these individuals.